학술논문
First efficacy assessment of a phase II study with cyclophosphamide, vincristine, liposomal doxorubicin, and prednisone plus rituximab, administered every two weeks (R-COMP-14) as primary treatment for NHL
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755